Source - SMW
Cell-based medicine company MaxCyte said it had appointed Richard Douglas as a non-executive director.

Douglas had served as senior vice president of corporate development at Genzyme Corporation. He was currently an adviser to RedSky Partners, a Biotechnology-focused advisory firm.


At 2:09pm: (LON:MXCT) MaxCyte Inc share price was 0p at 250p



Related Charts

MaxCyte Inc (MXCT)

0.00 (0.00%)
delayed 16:57PM